Welcome to Elusys Therapeutics, Inc. Elusys is a private, commercial-stage biopharmaceutical company that has achieved US and international licensure in Canada, the UK, and the EU for its lead antibody therapeutic, a medical countermeasure to treat patients following anthrax exposure after a natural or intentional terrorist incident. OUR PRODUCTS Learn more OUR PARTNERS About Us PRESS RELEASES December 2, […]
Location: United States, New Jersey, Tinton Falls
Investors 2
| Date | Name | Website |
| 14.05.2021 | EW Healthc... | ewhealthca... |
| - | Seed-One C... | seedone.co... |
Mentions in press and media 1
| Date | Title | Description |
| 26.09.2007 | Life sciences briefing: Wednesday, Sept. 26, 2007 | Featured companies: Ablynx, Cardiosolutions, Carigent Thereapeutics, Elusys, Genome Corp., GlobeImmune, Novazone, Targanta Therapeutics, Waterfront Media UPDATED at 5:45am on 9/27/07 GlobeImmune raises $41M for immune-system therapies — Glo... |